315 related articles for article (PubMed ID: 20973612)
1. Formulations of zero-order, pH-dependent, sustained release matrix systems by ionotropic gelation of alginate-containing mixtures.
Moroni A; Drefko W; Thone G
Drug Dev Ind Pharm; 2011 Feb; 37(2):216-24. PubMed ID: 20973612
[TBL] [Abstract][Full Text] [Related]
2. Oral liquid in situ gelling methylcellulose/alginate formulations for sustained drug delivery to dysphagic patients.
Shimoyama T; Itoh K; Kobayashi M; Miyazaki S; D'Emanuele A; Attwood D
Drug Dev Ind Pharm; 2012 Aug; 38(8):952-60. PubMed ID: 22283456
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of the characteristics of several polymer materials used in hydrophilic matrix tablets].
Nie SF; Liu H; Liu YL; Pan WS
Yao Xue Xue Bao; 2011 Mar; 46(3):338-43. PubMed ID: 21626791
[TBL] [Abstract][Full Text] [Related]
4. In situ gelling xyloglucan/alginate liquid formulation for oral sustained drug delivery to dysphagic patients.
Itoh K; Tsuruya R; Shimoyama T; Watanabe H; Miyazaki S; D'Emanuele A; Attwood D
Drug Dev Ind Pharm; 2010 Apr; 36(4):449-55. PubMed ID: 19788404
[TBL] [Abstract][Full Text] [Related]
5. Release behaviour of propranolol HCl from hydrophilic matrix tablets containing psyllium powder in combination with hydrophilic polymers.
Siahi-Shadbad MR; Asare-Addo K; Azizian K; Hassanzadeh D; Nokhodchi A
AAPS PharmSciTech; 2011 Dec; 12(4):1176-82. PubMed ID: 21918920
[TBL] [Abstract][Full Text] [Related]
6. Polymer film formulations for the preparation of enteric pharmaceutical capsules.
Smith AM; Ingham A; Grover LM; Perrie Y
J Pharm Pharmacol; 2010 Feb; 62(2):167-72. PubMed ID: 20487195
[TBL] [Abstract][Full Text] [Related]
7. Gastro-resistant characteristics of GRAS-grade enteric coatings for pharmaceutical and nutraceutical products.
Czarnocka JK; Alhnan MA
Int J Pharm; 2015; 486(1-2):167-74. PubMed ID: 25796126
[TBL] [Abstract][Full Text] [Related]
8. [Studies on the influencing factors on the drug release from sodium alginate matrices].
Nie SF; Wu XM; Liu HF; Jiang HW; Pan WS
Yao Xue Xue Bao; 2004 Jul; 39(7):561-5. PubMed ID: 15493851
[TBL] [Abstract][Full Text] [Related]
9. Guar gum, xanthan gum, and HPMC can define release mechanisms and sustain release of propranolol hydrochloride.
Mughal MA; Iqbal Z; Neau SH
AAPS PharmSciTech; 2011 Mar; 12(1):77-87. PubMed ID: 21174179
[TBL] [Abstract][Full Text] [Related]
10. Release behaviour of diclofenac sodium dispersed in Gelucire and encapsulated with alginate beads.
Al-Taani B; Khanfar MS; Salem MS; Sallam A
J Microencapsul; 2010; 27(1):10-3. PubMed ID: 20078392
[TBL] [Abstract][Full Text] [Related]
11. Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: development, optimization and in vitro-in vivo evaluation in healthy human volunteers.
Tadros MI
Eur J Pharm Biopharm; 2010 Feb; 74(2):332-9. PubMed ID: 19932750
[TBL] [Abstract][Full Text] [Related]
12. In situ cross-linking of sodium alginate with calcium and aluminum ions to sustain the release of theophylline from polymeric matrices.
Nokhodchi A; Tailor A
Farmaco; 2004 Dec; 59(12):999-1004. PubMed ID: 15598436
[TBL] [Abstract][Full Text] [Related]
13. Entrapment efficiency and release characteristics of polyethyleneimine-treated or -untreated calcium alginate beads loaded with propranolol-resin complex.
Halder A; Maiti S; Sa B
Int J Pharm; 2005 Sep; 302(1-2):84-94. PubMed ID: 16102927
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of Linum usitatisimum polysaccharide to prepare mucoadhesive beads of diclofenac sodium.
Saquib Hasnain M; Rishishwar P; Rishishwar S; Ali S; Nayak AK
Int J Biol Macromol; 2018 Sep; 116():162-172. PubMed ID: 29727643
[TBL] [Abstract][Full Text] [Related]
15. Preparation and evaluation of sustained release calcium alginate beads and matrix tablets of acetazolamide.
Barzegar-Jalali M; Hanaee J; Omidi Y; Ghanbarzadeh S; Ziaee S; Bairami-Atashgah R; Adibkia K
Drug Res (Stuttg); 2013 Feb; 63(2):60-4. PubMed ID: 23447074
[TBL] [Abstract][Full Text] [Related]
16. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
Sankalia JM; Sankalia MG; Mashru RC
J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
[TBL] [Abstract][Full Text] [Related]
17. A novel system for three-pulse drug release based on "tablets in capsule" device.
Li B; Zhu J; Zheng C; Gong W
Int J Pharm; 2008 Mar; 352(1-2):159-64. PubMed ID: 18055142
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of sodium alginate as drug release modifier in matrix tablets.
Liew CV; Chan LW; Ching AL; Heng PW
Int J Pharm; 2006 Feb; 309(1-2):25-37. PubMed ID: 16364576
[TBL] [Abstract][Full Text] [Related]
19. Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology.
Huang YB; Tsai YH; Lee SH; Chang JS; Wu PC
Int J Pharm; 2005 Jan; 289(1-2):87-95. PubMed ID: 15652202
[TBL] [Abstract][Full Text] [Related]
20. Swelling, erosion and release behavior of alginate-based matrix tablets.
Sriamornsak P; Thirawong N; Korkerd K
Eur J Pharm Biopharm; 2007 Jun; 66(3):435-50. PubMed ID: 17267187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
